    <SEC-DOCUMENT>0001628280-24-043761-index.html : 20241025
    <SEC-HEADER>0001628280-24-043761.hdr.sgml : 20241025
    <ACCEPTANCE-DATETIME>20241025080543
    ACCESSION NUMBER:		0001628280-24-043761
    CONFORMED SUBMISSION TYPE:	8-K
    PUBLIC DOCUMENT COUNT:		22
    CONFORMED PERIOD OF REPORT:	20241025
    ITEM INFORMATION:		Other Events
    ITEM INFORMATION:		Financial Statements and Exhibits
    FILED AS OF DATE:		20241025
    DATE AS OF CHANGE:		20241025

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			Aquestive Therapeutics, Inc.
    		CENTRAL INDEX KEY:			0001398733
    		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				208623253
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		8-K
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-38599
    		FILM NUMBER:		241394334

    	BUSINESS ADDRESS:
    		STREET 1:		30 TECHNOLOGY DRIVE
    		CITY:			WARREN
    		STATE:			NJ
    		ZIP:			07059
    		BUSINESS PHONE:		908-941-1900

    	MAIL ADDRESS:
    		STREET 1:		30 TECHNOLOGY DRIVE
    		CITY:			WARREN
    		STATE:			NJ
    		ZIP:			07059

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	MonoSol Rx, Inc.
    		DATE OF NAME CHANGE:	20070507
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>8-K
    <SEQUENCE>1
    <FILENAME>aqst-20241025.htm
    <DESCRIPTION>8-K
    <TEXT>
    Document 1 - file: aqst-20241025.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.1
    <SEQUENCE>2
    <FILENAME>aquestivetherapeutics-ac.htm
    <DESCRIPTION>EX-99.1
    <TEXT>
    Document 2 - file: aquestivetherapeutics-ac.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.2
    <SEQUENCE>3
    <FILENAME>acaai_abstracts-final.htm
    <DESCRIPTION>EX-99.2
    <TEXT>
    Document 3 - file: acaai_abstracts-final.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-99.3
    <SEQUENCE>4
    <FILENAME>acaai2024poster-final.htm
    <DESCRIPTION>EX-99.3
    <TEXT>
    Document 4 - file: acaai2024poster-final.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.SCH
    <SEQUENCE>5
    <FILENAME>aqst-20241025.xsd
    <DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
    <TEXT>
    Document 5 - file: aqst-20241025.xsd

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.LAB
    <SEQUENCE>6
    <FILENAME>aqst-20241025_lab.xml
    <DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
    <TEXT>
    Document 6 - file: aqst-20241025_lab.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EX-101.PRE
    <SEQUENCE>7
    <FILENAME>aqst-20241025_pre.xml
    <DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
    <TEXT>
    Document 7 - file: aqst-20241025_pre.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>8
    <FILENAME>acaai2024poster-final001.jpg
    <TEXT>
    Document 8 - file: acaai2024poster-final001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>9
    <FILENAME>acaai_abstracts-final001.jpg
    <TEXT>
    Document 9 - file: acaai_abstracts-final001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>10
    <FILENAME>aquestivetherapeutics-ac001.jpg
    <TEXT>
    Document 10 - file: aquestivetherapeutics-ac001.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>11
    <FILENAME>aquestivetherapeutics-ac002.jpg
    <TEXT>
    Document 11 - file: aquestivetherapeutics-ac002.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>12
    <FILENAME>aquestivetherapeutics-ac003.jpg
    <TEXT>
    Document 12 - file: aquestivetherapeutics-ac003.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>GRAPHIC
    <SEQUENCE>13
    <FILENAME>aquestivetherapeutics-ac004.jpg
    <TEXT>
    Document 13 - file: aquestivetherapeutics-ac004.jpg

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>15
    <FILENAME>R1.htm
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 15 - file: R1.htm

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>EXCEL
    <SEQUENCE>16
    <FILENAME>Financial_Report.xlsx
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 16 - file: Financial_Report.xlsx

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>17
    <FILENAME>Show.js
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 17 - file: Show.js

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>18
    <FILENAME>report.css
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 18 - file: report.css

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>20
    <FILENAME>FilingSummary.xml
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 20 - file: FilingSummary.html

    Document 20 - RAW XML: FilingSummary.xml

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>JSON
    <SEQUENCE>22
    <FILENAME>MetaLinks.json
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 22 - file: MetaLinks.json

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>ZIP
    <SEQUENCE>23
    <FILENAME>0001628280-24-043761-xbrl.zip
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 23 - file: 0001628280-24-043761-xbrl.zip

    </DOCUMENT>
    <DOCUMENT>
    <TYPE>XML
    <SEQUENCE>24
    <FILENAME>aqst-20241025_htm.xml
    <DESCRIPTION>IDEA: XBRL DOCUMENT
    <TEXT>
    Document 24 - file: aqst-20241025_htm.html

    Document 24 - RAW XML: aqst-20241025_htm.xml

    </DOCUMENT>
    </SEC-DOCUMENT>